P eroxisome proliferator-activated receptors (PPARs) are ligand-inducible transcription factors that belong to the nuclear hormone receptor superfamily. 1 In mammals, the PPAR family consists of 3 subtypes of proteins encoded by separate genes: PPAR␣ (NR1C1), PPAR␥ (NR1C3), and PPAR␦ (also known as ␤ or NR1C2). 2 They act as heterodimers with the retinoid X receptor and regulate gene transcription by binding to specific response elements in the promoter of the target genes. 3 The classical biological activity of PPAR␣ is the regulation of the rate of fatty acid uptake and their esterification into triglyceride or oxidation, 4 -7 whereas PPAR␥ is classically involved in adipocyte differentiation, regulation of fat storage, and maintenance of glucose homeostasis. 5 The physiological functions of PPAR␦ are instead still unclear, although it is known that this receptor contributes to an inflammatory switch through its association and disassociation with transcriptional repressors. 8 The clinical importance of PPARs originates with fibrates and thiazolidinediones (TZDs), which respectively act on PPAR␣ and PPAR␥ and are used to ameliorate hyperlipidemia and hyperglycemia in subjects with type 2 diabetes mellitus (T2DM). Fibrates, such as gemfibrozil, clofibrate, fenofibrate, and bezofibrate, are drugs that effectively reduce triglycerides (TG) and free fatty acids (FFA) and increase high-density lipoproteins-cholesterol. 9 -12 Fibrates also improve glucose tolerance in T2DM patients, although this activity might be attributable to the fact that some of these compounds also have potential PPAR␥ activity. 13 TZDs, such as rosiglitazone, pioglitazone, troglitazone, and ciglitazone, are insulin-sensitizing drugs and have constituted a major advance in the recent therapeutic management of T2DM. 14 -16 
ligand-inducible transcription factors that belong to the nuclear hormone receptor superfamily. 1 In mammals, the PPAR family consists of 3 subtypes of proteins encoded by separate genes: PPAR␣ (NR1C1), PPAR␥ (NR1C3), and PPAR␦ (also known as ␤ or NR1C2). 2 They act as heterodimers with the retinoid X receptor and regulate gene transcription by binding to specific response elements in the promoter of the target genes. 3 The classical biological activity of PPAR␣ is the regulation of the rate of fatty acid uptake and their esterification into triglyceride or oxidation, 4 -7 whereas PPAR␥ is classically involved in adipocyte differentiation, regulation of fat storage, and maintenance of glucose homeostasis. 5 The physiological functions of PPAR␦ are instead still unclear, although it is known that this receptor contributes to an inflammatory switch through its association and disassociation with transcriptional repressors. 8 The clinical importance of PPARs originates with fibrates and thiazolidinediones (TZDs), which respectively act on PPAR␣ and PPAR␥ and are used to ameliorate hyperlipidemia and hyperglycemia in subjects with type 2 diabetes mellitus (T2DM). Fibrates, such as gemfibrozil, clofibrate, fenofibrate, and bezofibrate, are drugs that effectively reduce triglycerides (TG) and free fatty acids (FFA) and increase high-density lipoproteins-cholesterol. 9 -12 Fibrates also improve glucose tolerance in T2DM patients, although this activity might be attributable to the fact that some of these compounds also have potential PPAR␥ activity. 13 TZDs, such as rosiglitazone, pioglitazone, troglitazone, and ciglitazone, are insulin-sensitizing drugs and have constituted a major advance in the recent therapeutic management of T2DM. 14 -16 In addition to improving insulin sensitivity, TZDs have also effects on TG, FFA, and ketone body level in several animal models of T2DM. The role of PPAR␦ remained unclear for almost a decade after its cloning in 1992. 17 Its near-ubiquitous tissue expression raised early speculation that it may serve a "general housekeeping role." 18 More recently, receptor knockouts revealed multiple developmental and homeostatic abnormalities in PPAR␦-null mice, including placental defects causing embryonic lethality, decreased adipose mass, myelination defects, altered skin inflammatory response, and impaired wound healing. 19 In recent years, there has been increasing appreciation of the fact that, in addition to the classical biological activities mentioned above, PPARs have several other pleiotropic functions. For instance, they provide a fundamental contribution to the regulation of certain physiological activities of the prostacyclin (PGI 2 ) system in cardiovascular tissues. 20 -24 Indeed, PGI 2 , which is the most abundant product of arachidonic acid in vascular tissues, 25 acts through a dual signaling pathway, that includes both G protein-coupled cell surface receptors named IP 26 and PPARs. 27 In this respect, it has been recently demonstrated that the angiogenic abilities of stable analogues of PGI 2 depend on their capacity to act on PPARs. 28 Additional evidence also suggests that selective activation of PPAR␣ and PPAR␥ promotes a robust angiogenic process in vitro and in vivo, through a mechanism that depends on the stimulation of the prototypical angiogenic agent vascular endothelial growth factor (VEGF). 29 Other data from our group also demonstrate that the ability of PGI 2 analogues to induce angiogenesis depends on the presence and proper function of the PPAR␣ gene. 30 In an article published in this issue of Circulation Research, He et al shed new light on the functional relationships existing between the PGI 2 system, angiogenesis, and the PPAR signaling pathway. 31 In particular, they demonstrate that endothelial progenitor cells (EPCs), a population of bone marrow-derived cells committed toward the endothelial lineage, express cyclooxygenase (COX)-1and PGI 2 and that activation of COX isoforms and high production of PGI 2 are important for the regenerative function of EPCs. In addition, by using stable PGI 2 analogues with different affinity for IP receptors and PPARs, the authors provide the elegant demonstration that activation of PPARs is fundamental for the angiogenic effects of PGI 2 in EPCs. They also identify PPAR␦ as the gene responsible for the regulation of PGI 2induced proliferation, in vitro tube formation, and in vivo capillary formation of EPCs.
This study adds substantially to the field. First of all, it demonstrates the importance of arachidonic acid metabolism and biosynthesis of PGI 2 in the mediation of the proangiogenic effects of human EPCs. Second, it strengthens the role of PPARs in angiogenesis. Third, it supports the notion that PPARs are also involved in EPC biology and function. Finally, it identifies a new biological activity for PPAR␦, a gene whose function in vascular biology is unclear and under intensive investigation. Particularly interesting is the demonstration that the proangiogenic effects of EPCs are modulated by PGI 2 via a PPAR-dependent pathway (Figure) . This concept is consistent with the findings of several recent reports that have demonstrated the ability of PPAR␥ to stimulate proliferation, differentiation, and therapeutic activity of EPCs in vitro and in vivo. [32] [33] [34] [35] However, the study by He et al is novel also in this respect, because it provides the first demonstration of PPAR␦ being involved in the regulation of EPC biological activities. So far, the only existing link between PPAR␦ and angiogenesis was the demonstration that the activation of this nuclear receptor induces proliferation of mature endothelial cells. 36 The intersection between the PGI 2 system, PPARs, and angiogenesis is intriguing and deserves further investigation. PPAR pleiotropy is another interesting field of research that might potentially improve our future understanding of the clinical effects of drugs that stimulate PPARs and are currently used in the clinic, with potentially important unexpected implications for the management of subjects with diabetes, hyperlipidemia, and ischemic cardiovascular diseases.
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Figure.
A schematic representation of PGI 2 activity on EPCs. The IP signaling mediates several effects, such as hyperpolarization, vasodilatation, and proliferation, but the PPAR signaling is crucial for angiogenic process.
